ER

EJNMMI Radiopharmacy and Chemistry

EJNMMI Radiopharmacy and Chemistry is a peer-reviewed journal focusing on the development of new imaging and radionuclide-based therapeutic agents for nuclear medicine and molecular imaging. It offers a platform for chemists, pharmacists, and basic scientists to present their work and publishes original research, review papers, guidelines, editorials, and letters to the editor. The journal specializes in novel radiochemistry, new radiopharmaceuticals, and molecular imaging agents, and also addresses legislative issues related to the production and safety of imaging and radionuclide therapy agents.

Looking to publish in EJNMMI Radiopharmacy and Chemistry? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Radiology, Nuclear Medicine & Medical Imaging
Impact Factor 3.3
Quartile Q1
Open Access Type Open
eISSN 2365-421X
Invitation Only No
Cost Range £1590.00 GBP / $2290.00 USD / €1990.00 EUR APC

Submission Instructions

EJNMMI Radiopharmacy and Chemistry accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published in EJNMMI Radiopharmacy and Chemistry, explain any issues relating to journal policies, declare any potential competing interests, confirm that all authors approved submission, confirm the manuscript has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Results, and Conclusions.
Manuscript Manuscript must include Background, Methods, Results, Discussion, Conclusions, and a Declarations section. Manuscript must include 3 to 10 keywords, define abbreviations at first use with a list of abbreviations if used, document any Large Language Model use in the Methods or another suitable section, and include all Declarations headings even if marked 'Not applicable'.
References References must use Vancouver style. Only published or in-press articles, clinical trial registration records, abstracts, and items available through public e-print or preprint servers may be cited, unpublished abstracts, unpublished data, and personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, and web links must be numbered and listed as full references with title, full URL, and access date.
Figures & Tables Tables must be included in the main manuscript file, with tables larger than one page placed at the end and their intended location indicated in the text, while figures must be uploaded separately in the order first cited. Multi-panel figures must be submitted as a single composite file, figure titles and legends must appear in the manuscript rather than the image file, figure keys must be included within the graphic, and tables must not be submitted as figures or spreadsheet files.
Reformat to EJNMMI Radiopharmacy and Chemistry using Livewrite Premium

Reviews

Cover Letter Cover letter is required. Cover letter must explain why the manuscript should be published, address any journal policy issues, declare any potential competing interests, confirm all authors approved submission, confirm the content has not been published or submitted elsewhere, include the special issue name if applicable, and disclose any preprint posting details.
Abstract Abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include Background, Main body of the abstract, and short Conclusion.
Manuscript Manuscript must include Background, Main text, Conclusions, and a Declarations section containing Ethics approval and consent to participate, Consent for publication, Availability of data and material, Competing interests, Funding, Authors' contributions, and Acknowledgements. Reviews must include three to ten keywords, document any Large Language Model use in the Methods section or suitable alternative, provide an Availability of data and materials statement, include a list of abbreviations if abbreviations are used, and state 'Not applicable' for any non-relevant Declarations subsection.
References References must follow Vancouver style. Only published or in-press articles, clinical trial registration records, and abstracts or items available through public e-print or preprint servers may be cited, unpublished abstracts, unpublished data, and personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, web links must appear in the numbered reference list, and dataset identifiers including DOIs must be given as full URLs.
Figures & Tables Tables must be included in the main manuscript file, with tables larger than one A4 or Letter page indicated in the text for placement, while figures must be uploaded separately in the order first mentioned in the text. Multi-panel figures must be submitted as a single composite file and figure keys placed within the graphic, while tables must not be submitted as figures and must be created using the word processor's table function without color or shading.
Reformat to EJNMMI Radiopharmacy and Chemistry using Livewrite Premium

Guideline Articles

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published, explain any issues relating to journal policies, declare any potential competing interests, confirm all authors approved the submission, and confirm the manuscript has not been published or submitted elsewhere.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Results, and Conclusions.
Manuscript Manuscript must include a title page, structured abstract, keywords, a Methods section, a Results section, a Conclusions section, and a Declarations section. Manuscript must include three to ten keywords, a list of abbreviations if abbreviations are used, a Declarations section with all subsection headings retained and marked 'Not applicable' when irrelevant, and documentation of any Large Language Model use in the Methods section or another suitable section.
References References must follow Vancouver style. Only published or in-press articles, clinical trial registration records, and abstracts or items available through public e-print/preprint servers may be cited, unpublished abstracts, unpublished data, and personal communications must not appear in the reference list, web references must include the site title, full URL, and access date, and journal abbreviations must follow Index Medicus/MEDLINE.
Figures & Tables Tables must be included in the main manuscript file, with tables under one page placed in the text and larger tables allowed at the end of the document, while figures must be uploaded separately in the order first cited. Multi-panel figures must be submitted as a single composite file, figure titles and legends must appear in the manuscript rather than the image file, and tables must not be submitted as figures and must be created using the word processor's table function without color or shading.
Reformat to EJNMMI Radiopharmacy and Chemistry using Livewrite Premium

Letters To The Editor

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved submission, confirm the content has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract An abstract is not required.
Manuscript The body of the letter must not exceed 500 words. The letter must start with "To the Editor" and may be divided into subsections with short, informative headings. The manuscript must include a Declarations heading with Funding, Authors' contributions, and Acknowledgements sections, using "Not applicable" where a listed section is not relevant.
References References must use Vancouver style. Only published or in-press articles, clinical trial registration records, abstracts, or public e-print/preprint items may be cited, unpublished abstracts, unpublished data, and personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, and web links must be numbered and included in the reference list in full.
Figures & Tables Tables should be included in the main manuscript file, with tables under one page placed in the text and larger tables placed at the end, while figure titles and legends must appear in the main manuscript and figures must be uploaded separately. Figure titles must not exceed 15 words, figure legends and table legends must not exceed 300 words, table titles must not exceed 15 words, and tables must not be submitted as figures.
Reformat to EJNMMI Radiopharmacy and Chemistry using Livewrite Premium

Short Communications

Cover Letter A cover letter is required. Cover letter must explain why the manuscript should be published, address any issues relating to journal policies, declare any potential competing interests, confirm all authors approved submission, confirm the manuscript has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract An abstract is required. Abstract must not exceed 350 words.
Manuscript Main text may be broken into subsections with short, informative headings and must include a 'Declarations' heading. If abbreviations are used a list of abbreviations must be provided, any use of a Large Language Model must be documented in the Methods section or suitable alternative, and the manuscript must include Declarations sections for Ethics approval and consent to participate, Consent for publication, Availability of data and material, Competing interests, Funding, Authors' contributions, Acknowledgements, and Authors' information (optional), using 'Not applicable' where a section is irrelevant.
References Only published or in-press articles, clinical trial registration records, abstracts, and public e-print or preprint items may be cited, unpublished abstracts, unpublished data, and personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, and web links must be included in the reference list as full references.
Figures & Tables Figure titles and legends must appear in the main manuscript rather than the graphic file, and tables must be included in the main manuscript file with larger tables placed at the end and their location indicated in the text. Figures must be numbered in text order and multi-panel figures submitted as a single composite file, while table and figure titles must not exceed 15 words and legends must not exceed 300 words.
Reformat to EJNMMI Radiopharmacy and Chemistry using Livewrite Premium

Recent Publications

Expanding 68Ga radiolabeling capacity: off-label use of PSMA-11 single vial cold kits through aliquoting and dual generator utilization

Olivier Perrin, Sarah Benkhoris, Johanne Vanney, Laurie Barthelemi, Vincent Boudousq, Emmanuel Deshayes, Claire Guisset, Ian Soulairol, Léa Rubira, Cyril Fersing, Daniele Alizé

10.1186/s41181-026-00459-7
View Publication

Development of NOTA-based antibody-fragment labeling agent that reduces early renal radioactivity levels

Shunsuke Katamoto, Hiroyuki Suzuki, Madoka Kobayashi, Shota Kise, Kento Kannaka, Nobuki Kazuta, Tomoya Uehara

10.1186/s41181-026-00460-0
View Publication

Design and development of a semi-automated solid target assembly for the indigenous production of medical radioisotopes in the PETrace-800 cyclotron

Kanchan Kushwaha, Kavindra Pathak, Tejinder P. Sabharwal, Sunil Kamble, Arpit Mitra, Sudeep Sahu, Pravind Maletha, Nand Kishore Prasad, Manish Kumar, Sharmila Banerjee

10.1186/s41181-026-00448-w
View Publication

Quality and pratical determinants in [99mTc]Tc-tetrofosmin preparation: hygrometry, syringe sorption & maximal activity per kit

Quentin Buon, Hugo Tep, Eli Bassi, Pr Alessio Imperiale, Anne Dory, Bénédicte Gourieux, Alice Ressault

10.1186/s41181-026-00454-y
View Publication

Development of an automated radiosynthesis for [68Ga]Ga-NODAGA[40Lys]-Exendin-4 in sodium acetate buffer

Maïlys Ragot, Pauline Reynaud-Orhon, Alban Revy, Marie Batisse-Lignier, Valentin Brusseau, Antony Kelly, Hosameldin Otman, Florent Cachin, Marion Chanchou, Sophie Levesque, Marion Tempier

10.1186/s41181-026-00452-0
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A cover letter is required and should explain why the manuscript should be published in EJNMMI Radiopharmacy and Chemistry, address any issues relating to journal policies, declare potential competing interests, confirm all authors approved the submission, confirm the work has not been published or submitted elsewhere, and identify the special issue if applicable. Authors may also suggest preferred and non-preferred peer reviewers in the cover letter.

Reformat to EJNMMI Radiopharmacy and Chemistry using Livewrite Premium

What are the publication costs?

Article processing charge: £1590.00 GBP / $2290.00 USD / €1990.00 EUR, plus VAT or local taxes where applicable.

Reformat to EJNMMI Radiopharmacy and Chemistry using Livewrite Premium

Research Topics

Radiopharmaceutical Chemistry and Applications Medical Imaging Techniques and Applications Peptidase Inhibition and Analysis Radioactive Decay and Measurement Techniques Prostate Cancer Treatment and Research Neuroendocrine Tumor Research Advances Chemical Reactions and Isotopes Medical Imaging and Pathology Studies Monoclonal and Polyclonal Antibodies Research Cancer, Hypoxia, and Metabolism Click Chemistry and Applications Lung Cancer Treatments and Mutations Neuropeptides and Animal Physiology Lanthanide and Transition Metal Complexes Orthopedic Infections and Treatments Boron Compounds in Chemistry Glioma Diagnosis and Treatment Radiation Therapy and Dosimetry Amino Acid Enzymes and Metabolism Chemical Synthesis and Analysis Fluorine in Organic Chemistry Lung Cancer Research Studies Orthopaedic implants and arthroplasty Drug Transport and Resistance Mechanisms HER2/EGFR in Cancer Research

Related Journals

BM
BMC Medical Imaging BioMed Central
RA
Radiology Artificial Intelligence Radiological Society of North America
AO
Archives of Pharmacal Research Springer Nature
AJ
American Journal of Neuroradiology American Society of Neuroradiology
IJ
International Journal of Hyperthermia Taylor & Francis
Ey
Eye Springer Nature